This inventor holds 2 USPTO granted patents. Top assignee: University of Iowa Research Foundation. Active years: 2010-2016.
Company Filing History:
Years Active: 2010-2016
Title: Thomas Prisinzano: Innovator in Opioid Receptor Ligands
Introduction
Thomas Prisinzano is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of therapeutic compounds that target opioid receptors. With a total of 2 patents, his work is pivotal in addressing issues related to opioid receptor function.
Latest Patents
Prisinzano's latest patents focus on novel compounds that serve as opioid receptor ligands. The first patent details the invention of compounds of formula I, which are designed to modulate opioid receptor function. These compounds are not only useful in treating diseases associated with opioid receptor function but also include pharmaceutical compositions for effective administration to mammals in need of treatment. The second patent further elaborates on the preparation of these opioid receptor ligands and provides an improved method for isolating intermediate materials necessary for obtaining the compounds of formula I.
Career Highlights
Thomas Prisinzano is affiliated with the University of Iowa Research Foundation, where he conducts his research and development activities. His work has garnered attention for its potential impact on therapeutic strategies for managing conditions related to opioid receptors.
Collaborations
Prisinzano collaborates with Richard B Rothman, a fellow researcher in the field. Their combined expertise enhances the research efforts aimed at developing effective treatments for opioid-related conditions.
Conclusion
Thomas Prisinzano's innovative work in the realm of opioid receptor ligands showcases his commitment to advancing pharmaceutical science. His contributions are vital in the ongoing efforts to improve treatment options for diseases associated with opioid receptor function.